Launch of ADH MASTR™ v2
Niel, February 17th, 2015 – We are pleased to announce the release of the new ADH MASTR™ v2 molecular assay, research use only, which is an update of the current ADH MASTR™ assay.
Multiplicom offers clinical labs early access to its innovative non-invasive prenatal test
Niel, February 10th, 2015 – Multiplicom N.V. today announces that it is enrolling molecular diagnostic laboratories in an Early Access Program (EAP) to complete the development of its innovative non-invasive prenatal test (NIPT) branded “Clarigo”. Clarigo identifies fetal aneuploidy – abnormalities of the chromosome number - through the analysis of free circulating DNA isolated from the mother’s blood.
15th annual meeting of the BeSHG
Bridging the Gap - ASOC and MGSA Meeting
Auckland, New Zealand
Technical Workshop: Integrated germline MASTR solutions for clinical diagnostics and new NIAT test